Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: A pilot study

Respiratory Care

Volumn 58, Issue 12, 2013, Pages 2134-2141

  Dimopoulos, Stavros ^a   Tzanis, Georgios ^a   Manetos, Christos ^a   Tasoulis, Athanasios ^a   Mpouchla, Anthi ^a   Tseliou, Eleni ^a   Vasileiadis, Ioannis ^a   Diakos, Nikos ^a   Terrovitis, John ^a   Nanas, Serafim ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Endothelium; Hyperoxia; Microcirculation; Near infrared spectroscopy; Oxygen breathing; Pulmonary arterial hypertension

Indexed keywords

HEMOGLOBIN; OXYGEN;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; EVOKED RESPONSE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SIZE; HUMAN; HYPEREMIA; HYPEROXIA; LUNG MICROCIRCULATION; MALE; MICROANGIOPATHY; MICROCIRCULATION; MICROVASCULATURE; NEAR INFRARED SPECTROSCOPY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PERIPHERAL MUSCLE MICROCIRCULATION; PERIPHERAL MUSCLE MICROCIRCULATORY ALTERATION; PILOT STUDY; PULMONARY HYPERTENSION; REPERFUSION; THENAR; TREND STUDY; VASOCONSTRICTION;

ENDOTHELIUM; HYPEROXIA; MICROCIRCULATION; NEAR-INFRARED SPECTROSCOPY; OXYGEN BREATHING; PULMONARY ARTERIAL HYPERTENSION;

ADULT; AGED; FEMALE; HEART FAILURE; HUMANS; HYPEREMIA; HYPERTENSION, PULMONARY; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY; PILOT PROJECTS; REPERFUSION; RESEARCH DESIGN; SPECTROSCOPY, NEAR-INFRARED; TIME FACTORS;

EID: 84888085125     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02113     Document Type: Article

References (36)

1. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension 1982-2006. Eur Respir J 2007;30(6):1103-1110.
2. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society; Pulmonary Hypertension Assocation. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. Circulation 2009;119(16):2250-2294. Erratum in: Circulation 2009;120(2):e13.
3. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109(2):159-165.
4. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991;114(6):464-469.
5. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333(4):214-221.
6. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327(2):70-75.
7. Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 2007;153(6):1088. e1-e7.
8. Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. Respir Med 2008;102(12):1791-1796.
9. Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol 2009;36(5):970-975.
10. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131(6):1917-1928.
11. De Blasi RA, Cope M, Elwell C, Safoue F, Ferrari M. Non-invasive measurement of human forearm oxygen consumption by near infrared spectroscopy. Eur J Appl Physiol Occup Physiol 1993;67(1): 20-25.
12. Siafaka A, Angelopoulos E, Kritikos K, Poriazi M, Basios N, Gerovasili V, et al. Acute effects of smoking on skeletal muscle microcirculation monitored by near-infrared spectroscopy. Chest 2007;131(5):1479-1485.
13. Nanas S, Gerovasili V, Dimopoulos S, Pierrakos C, Kourtidou S, Kaldara E, et al. Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure. J Card Fail 2008;14(5):400-406.
14. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E, Dimopoulos S, et al. Physical exercise improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm Rehabil Prev 2009;29(6):385-391.
15. Abozguia K, Phan TT, Shivu GN, Maher AR, Ahmed I, Wagenmakers A, Frenneaux MP. Reduced in vivo skeletal muscle oxygen consumption in patients with chronic heart failure: a study using Near Infrared Spectrophotometry (NIRS). Eur J Heart Fail 2008; 10(7):652-657.
16. Nanas S, Gerovasili V, Renieris P, Angelopoulos E, Poriazi M, Kritikos K, et al. Non invasive assessment of the microcirculation in critically ill patients. Anaesth Intensive Care 2009;37(5):700-702.
17. Gerovasili V, Dimopoulos S, Tzanis G, Anastasiou-Nana M, Nanas S. Utilizing the vascular occlusion technique with NIRS technology. Int J Ind Ergon 2010;40(2):218-222.
18. Manetos C, Dimopoulos S, Tzanis G, Vakrou S, Tasoulis A, Kapelios C, et al. Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure. J Heart Lung Transplant 2011;30(12):1403-1408.
19. Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144(1):1-2.
20. Mancini DM, Bolinger L, Li H, Kendrick K, Chance B, Wilson JR. Validation of near infrared spectroscopy in humans. J Appl Physiol 1994;77(6):2740-2747.
21. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 2004;110(10):1308-1312.
22. Dimopoulos S, Anastasiou-Nana M, Katsaros F, Papazachou O, Tzanis G, Gerovasili V, et al. Impairment of autonomic nervous system activity in patients with pulmonary arterial hypertension: a case control study. J Cardiac Fail 2009;15(10):882-889.
23. Wensel R, Jilek C, Dörr M, Francis DP, Stadler H, Lange T, et al. Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J 2009;34(4):792-794.
24. Bauer R, Dehnert C, Schoene P, Filusch A, Bärtsch P, Borst MM, et al. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 2007;101(11):2366-2369.
25. Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M, Provencher S. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 2010;65(2):113-117.
26. Gabrielli LA, Castro PF, Godoy I, Mellado R, Bourge RC, Alcaino H, et al. Systemic oxidative stress and endothelial dysfunction is associated with an attenuated acute vascular response to inhaled prostanoid in pulmonary artery hypertension patients. J Card Fail 2011;17(12):1012-1017.
27. Friedman D, Szmuszkovicz J, Rabai M, Detterich JA, Menteer J, Wood JC. Systemic endothelial dysfunction in children with idiopathic pulmonary arterial hypertension correlates with disease severity. J Heart Lung Transplant 2012;31(6):642-647.
28. Haneda T, Nakajima T, Shirato K, Onodera S, Takishima T. Effects of oxygen breathing on pulmonary vascular input impedance in patients with pulmonary hypertension. Chest 1983;83(3):520-527.
29. Daly WJ, Bondurant S. Effects of oxygen breathing on the heart rate, blood pressure, and cardiac index of normal men, resting, with reactive hyperemia, and after atropine. J Clin Invest 1962;41:126-132.
30. Waring WS, Thomson AJ, Adwani SH, Rosseel AJ, Potter JF, Webb DJ, Maxwell SR. Cardiovascular effects of acute oxygen administration in healthy adults. J Cardiovasc Pharmacol 2003;42(2): 245-250.
31. Frøbert O, Holmager P, Jensen KM, Schmidt EB, Simonsen U. Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardiovascular risk. Scand Cardiovasc J 2008;42(1): 38-47.
32. Gole Y, Gargne O, Coulange M, Steinberg JG, Bouhaddi M, Jammes Y, et al. Hyperoxia-induced alterations in cardiovascular function and autonomic control during return to normoxic breathing. Eur J Appl Physiol 2011;111(6):937-946.
33. Krongrad E, Helmholz HF, Ritter DG. Effect of breathing oxygen in patients with severe pulmonary vascular obstructive disease. Circulation 1973;47(1):94-100.
34. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 2009;95(3):198-202.
35. Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Beasley R. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 2009;158(3): 371-377.
36. Park JH, Balmain S, Berry C, Morton JJ, McMurray JJ. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart 2010;96(7):533-538.